Paper109598
Nephrotic syndrome in children: a randomized trial comparing two prednisone regimens in steroid-responsive patients who relapse early. Report of the international study of kidney disease in children.
J Pediatr, 1979. Cited by 78 papers, by iCite.
Cite this record
ConductScience Library. Nephrotic syndrome in children: a randomized trial comparing two prednisone regimens in steroid-responsive patients who relapse early. Report of the international study of kidney disease in children. Papers, record 109598. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/109598
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Nephrotic syndrome in children: a randomized trial comparing two prednisone regimens in steroid-responsive patients who relapse early. Report of the international study of kidney disease in children.
- PubMed
- Publication types
- Clinical Trial, Journal Article, Randomized Controlled Trial, Research Support, U.S. Gov't, P.H.S.
- PubMed
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Nephrotic Syndrome | Major topic |
| Prednisone | Major topic |
| Adolescent | |
| Age Factors | |
| Child | |
| Child, Preschool | |
| Clinical Trials as Topic | |
| Follow-Up Studies | |
| Humans | |
| Infant | |
| Long-Term Care | |
| Recurrence | |
| Time Factors |
Source PubMed
Cited by46
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 78 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41910850 | Nephrotic Syndrome: Current Management. | Indian J Pediatr | 2026 | https://conductscience.org/library/papers/41910850 | PubMed |
| 40731886 | Management of Nephrotic Syndrome in Pediatric Patients Treated by Different Steroid Regimens. | Medicina (Kaunas) | 2025 | https://conductscience.org/library/papers/40731886 | PubMed |
| 39797329 | Successful Switch to Obinutuzumab in a Rituximab-Intolerant Child with Difficult-to-Treat Idiopathic Nephrotic Syndrome. | J Clin Med | 2025 | https://conductscience.org/library/papers/39797329 | PubMed |
| 39171624 | Corticosteroid therapy for nephrotic syndrome in children. | Cochrane Database Syst Rev | 2024 | https://conductscience.org/library/papers/39171624 | PubMed |
| 39126675 | Approach to the Pediatric Patient With Glucocorticoid-Induced Osteoporosis. | J Clin Endocrinol Metab | 2025 | https://conductscience.org/library/papers/39126675 | PubMed |
| 38752042 | Incidence and Pathological Patterns of Nephrotic Syndrome among Infants and Children: A Systematic Review. | Cureus | 2024 | https://conductscience.org/library/papers/38752042 | PubMed |
| 38435073 | Mycophenolate Mofetil Versus Prednisone for Induction Therapy in Steroid-Sensitive Idiopathic Nephrotic Syndrome in Children: An Observational Study. | Kidney Med | 2024 | https://conductscience.org/library/papers/38435073 | PubMed |
| 36625931 | The first randomized controlled trial in pediatric nephrology: the history of the International Study of Kidney Disease in Children (ISKDC). | Pediatr Nephrol | 2023 | https://conductscience.org/library/papers/36625931 | PubMed |
| 36405821 | Duration of initial prednisolone therapy for first episode of childhood nephrotic syndrome based on time to response. | Front Pediatr | 2022 | https://conductscience.org/library/papers/36405821 | PubMed |
| 35659203 | Corticosteroid therapy for nephrotic syndrome in children. | Cochrane Database Syst Rev | 2020 | https://conductscience.org/library/papers/35659203 | PubMed |
| 35251836 | Clinico-Biochemical Profile and Identification of Independent Risk Factors of Frequent Relapse in Childhood-Onset Steroid-Sensitive Nephrotic Syndrome. | Cureus | 2022 | https://conductscience.org/library/papers/35251836 | PubMed |
| 34621271 | CyTOF-Enabled Analysis Identifies Class-Switched B Cells as the Main Lymphocyte Subset Associated With Disease Relapse in Children With Idiopathic Nephrotic Syndrome. | Front Immunol | 2021 | https://conductscience.org/library/papers/34621271 | PubMed |
| 34245406 | Part I: Which Child with a Chronic Disease Needs Bone Health Monitoring? | Curr Osteoporos Rep | 2021 | https://conductscience.org/library/papers/34245406 | PubMed |
| 34091756 | Pediatric idiopathic steroid-sensitive nephrotic syndrome: diagnosis and therapy -short version of the updated German best practice guideline (S2e) - AWMF register no. 166-001, 6/2020. | Pediatr Nephrol | 2021 | https://conductscience.org/library/papers/34091756 | PubMed |
| 33861375 | Low-dose versus conventional-dose prednisolone for nephrotic syndrome relapses: a randomized controlled non-inferiority trial. | Pediatr Nephrol | 2021 | https://conductscience.org/library/papers/33861375 | PubMed |
| 33391179 | Glucocorticoid-Induced Osteoporosis: Why Kids Are Different. | Front Endocrinol (Lausanne) | 2020 | https://conductscience.org/library/papers/33391179 | PubMed |
| 32297308 | Non-corticosteroid immunosuppressive medications for steroid-sensitive nephrotic syndrome in children. | Cochrane Database Syst Rev | 2020 | https://conductscience.org/library/papers/32297308 | PubMed |
| 32201918 | Efficacy of body weight vs body surface area-based prednisolone regimen in nephrotic syndrome. | Clin Exp Nephrol | 2020 | https://conductscience.org/library/papers/32201918 | PubMed |
| 30368613 | Equations to estimate prednisone dose using body weight. | Pediatr Nephrol | 2019 | https://conductscience.org/library/papers/30368613 | PubMed |
| 30194663 | Efficacy of low-dose daily versus alternate-day prednisolone in frequently relapsing nephrotic syndrome: an open-label randomized controlled trial. | Pediatr Nephrol | 2019 | https://conductscience.org/library/papers/30194663 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Authors
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/109598
GET https://conductscience.org/api/papers/v1/109598/cited_by?page=2